| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |